GSA CAPITAL PARTNERS LLP - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 119 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$152
-63.5%
17,468
-73.7%
0.02%
-71.2%
Q4 2022$416
-99.9%
66,329
-33.0%
0.05%
+13.0%
Q3 2022$347,000
+89.6%
99,029
+59.2%
0.05%
+70.4%
Q2 2022$183,000
-69.4%
62,194
-67.6%
0.03%
-66.2%
Q1 2022$598,000
-23.1%
192,244
-16.5%
0.08%
-18.4%
Q4 2021$778,000
-19.3%
230,258
-12.9%
0.10%0.0%
Q3 2021$964,000
+69.1%
264,224
+102.2%
0.10%
+53.1%
Q2 2021$570,000
-32.6%
130,672
-29.9%
0.06%
-54.3%
Q1 2021$846,000
-3.5%
186,317
+21.9%
0.14%
-2.1%
Q4 2020$877,000
+126.6%
152,797
-22.6%
0.14%
+217.8%
Q4 2019$387,000
+64.0%
197,290
+327.9%
0.04%
+40.6%
Q3 2019$236,000
-22.1%
46,103
+9.0%
0.03%
-5.9%
Q2 2019$303,000
-56.3%
42,285
-32.3%
0.03%
-10.5%
Q3 2018$693,000
+13.8%
62,500
-5.6%
0.04%
+2.7%
Q4 2017$609,000
-50.0%
66,200
-56.2%
0.04%
-55.4%
Q3 2017$1,218,000151,1000.08%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders